Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -480.00K | -1.24M | -4.77M | -8.42M | -8.44M |
Total Depreciation and Amortization | 2.18M | 2.19M | 2.21M | 1.83M | 1.44M |
Total Amortization of Deferred Charges | 426.00K | 1.17M | 1.17M | 1.23M | 1.11M |
Total Other Non-Cash Items | 3.60M | 3.22M | 3.68M | 3.81M | 3.72M |
Change in Net Operating Assets | -1.53M | -2.04M | -7.02M | -6.37M | -7.24M |
Cash from Operations | 4.20M | 3.29M | -4.73M | -7.92M | -9.41M |
Capital Expenditure | -1.01M | -659.00K | -484.00K | -278.00K | -284.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | 0.00 | -12.36M | -12.36M | -12.36M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -3.86M | -1.87M | 6.14M | 4.15M | 9.60M |
Cash from Investing | -4.87M | -2.53M | -6.71M | -8.49M | -3.05M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -1.20M | -2.74M | -3.27M | -3.27M | -3.51M |
Issuance of Common Stock | 10.18M | 7.49M | 17.62M | 15.42M | 14.86M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -1.63M | -938.00K | -5.00K | -5.00K | -5.00K |
Cash from Financing | 7.35M | 3.81M | 14.35M | 12.15M | 11.34M |
Foreign Exchange rate Adjustments | -5.00K | -3.00K | -3.00K | -1.00K | -4.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 6.68M | 4.58M | 2.90M | -4.25M | -1.12M |